Orphenadrine Citrate Aspirin Caffeine
NDC 50564-555

View dosage, usage, ingredients, routes, and UNII mappings.
Table of Contents
  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 50564-555?
  5. Orphenadrine Citrate Aspirin Caffeine Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Orphenadrine Citrate Aspirin Caffeine is a ANDA-approved product labeled by Jerome Stevens Pharmaceuticals, Inc.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a green product. This product entry covers the primary NDC 50564-555 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
50564-555
Proprietary Name:
Orphenadrine Citrate Aspirin Caffeine
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:

Labeler & Regulatory Data

Labeler Name: [5]
Jerome Stevens Pharmaceuticals, Inc.
Labeler Code:
50564
Product Label ID:
b49dd596-1f6a-4ff7-8079-e55bbcca8fbd
FDA Application Number: [6]
ANDA074988
Marketing Category: [8]
ANDA - A product marketed under an approved Abbreviated New Drug Application.

Marketing Timeline

Start Marketing Date: [9]
04-30-1999
Listing Expiration Date: [11]
12-31-2025
Exclude Flag: [12]
I

Product Characteristics

Color(s):
GREEN (C48329 - GREEN)
WHITE (C48325 - WHITE)
YELLOW (C48330 - YELLOW)
Shape:
ROUND (C48348)
CAPSULE (C48336)
Size(s):
11 MM
19 MM
Imprint(s):
JSP;554
JSP;555
Score:
1
2

Code Structure Chart

Product Details

What is NDC 50564-555?

The NDC code 50564-555 is assigned by the FDA to the product Orphenadrine Citrate Aspirin Caffeine. This pharmaceutical product is labeled by Jerome Stevens Pharmaceuticals, Inc. and is currently categorized as listed product. In terms of distribution, this product is available in 2 different package configurations. The associated package NDC(s) include: 50564-555-01, 50564-555-05. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. These products do not directly relax tense skeletal muscles in man.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are the Inactive Ingredients associated UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 994528 - orphenadrine citrate 25 MG / aspirin 385 MG / caffeine 30 MG Oral Tablet
  • RxCUI: 994528 - aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet
  • RxCUI: 994528 - ASA 385 MG / Caffeine 30 MG / Orphenadrine Citrate 25 MG Oral Tablet
  • RxCUI: 994535 - orphenadrine citrate 50 MG / aspirin 770 MG / caffeine 60 MG Oral Tablet
  • RxCUI: 994535 - aspirin 770 MG / caffeine 60 MG / orphenadrine citrate 50 MG Oral Tablet

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".